Silence Therapeutics (SLN) Receivables - Net: 2019-2025
Historic Receivables - Net for Silence Therapeutics (SLN) over the last 7 years, with Sep 2025 value amounting to $28,000.
- Silence Therapeutics' Receivables - Net fell 92.52% to $28,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $28,000, marking a year-over-year decrease of 92.52%. This contributed to the annual value of $972,000 for FY2024, which is 235.17% up from last year.
- As of Q3 2025, Silence Therapeutics' Receivables - Net stood at $28,000, which was down 67.06% from $85,000 recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Receivables - Net registered a high of $15.4 million during Q2 2023, and its lowest value of $28,000 during Q3 2025.
- In the last 3 years, Silence Therapeutics' Receivables - Net had a median value of $585,208 in 2023 and averaged $2.9 million.
- Its Receivables - Net has fluctuated over the past 5 years, first surged by 496.74% in 2022, then plummeted by 99.60% in 2025.
- MRQ analysis of 5 years shows Silence Therapeutics' Receivables - Net stood at $446,191 in 2021, then soared by 140.53% to $1.1 million in 2022, then tumbled by 72.98% to $290,000 in 2023, then soared by 235.17% to $972,000 in 2024, then plummeted by 97.12% to $28,000 in 2025.
- Its Receivables - Net was $28,000 in Q3 2025, compared to $85,000 in Q2 2025 and $41,000 in Q1 2025.